![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 18, 2017 7:52:08 PM
There will ne no Reverse split. Why would they release such news on a Friday? Because this is a strategic move to make money and the MM's will lend themselves to also make money.
See my previous post.
"Under the pact, CytRx will also gain increasing double-digit royalties for sales of aldoxorubicin, should it gain approval, for STS, and mid- to high-single-digit royalties for any and all other indications. The biobucks deal could be worth over $350 million, but a lot needs to go right for that to be realized.
NantCell will be responsible for all future development, manufacturing and commercialization expenses, it said in a brief update. CytRx has also issued NantCell a warrant to purchase up to 3 million shares of common stock, also at $1.10, over the next year and a half."
The only reason why nantcell would commit to something like that if if they knew they were going to make money on it.
One thing is for sure if I had 13 million dollars to invest I better be sure I'm going to make money on it not lose it right?
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM